XML 18 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:    
Net income $ 36,652 $ 36,029
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 8,289 4,340
Amortization of debt issuance costs 148 148
Provision for doubtful accounts 2,222 (1,581)
Share-based compensation 3,255 2,921
Deferred income taxes 1,845 548
Excess tax benefits from share-based payment arrangements (101) (260)
Change in fair value of contingent consideration 3,381 976
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (19,424) (20,985)
Inventories (49,148) (14,214)
Prepaid expenses and other assets (9,699) 1,448
Other non-current assets (3,902) (407)
Accounts payable (24,748) (11,173)
Accrued expenses and other liabilities 12,287 (1,009)
Income taxes payable (1,517) (6,444)
Net cash provided by (used in) operating activities (40,460) (9,663)
Cash flows from investing activities:    
Capital expenditures (3,466) (13,783)
Cash paid for business acquisitions, net of cash acquired (61,475) (35,516)
Net cash provided by (used in) investing activities (64,941) (49,299)
Cash flows from financing activities:    
Borrowings (repayments) on short-term borrowings, net 0 (4,609)
Borrowings on revolving credit 667,908 0
Repayments on revolving credit (558,919) 0
Repayments on long-term debt (2,019) 0
Repayments on capital lease obligation (122) (141)
Contingent consideration payments (7,286) (5,529)
Exercise of stock options 678 249
Repurchase of common stock (71,587) 0
Excess tax benefits from share-based payment arrangements 101 260
Net cash provided by (used in) financing activities 28,754 (9,770)
Effect of exchange rate changes on cash and cash equivalents (5,561) (4,606)
Increase (decrease) in cash and cash equivalents (82,208) (73,338)
Cash and cash equivalents at beginning of period 121,646 194,851
Cash and cash equivalents at end of period $ 39,438 $ 121,513